Results 201 to 210 of about 148,322 (271)

Impact of leaving periodontal disease untreated on healthcare expenditures: A retrospective cohort study

Journal of Periodontology, EarlyView.
Abstract Background This study aimed to investigate whether healthcare expenditures (HCEs) differed depending on whether the patients left periodontal disease (PD) untreated, despite the need for treatment. Methods This study used public PD screening data from a municipality in Japan to identify adults aged ≥ 40 years who were found to require ...
Anna Kinugawa, Kenji Takeuchi, Yudai Tamada, Taro Kusama, Futoshi Oda, Megumi Maeda, Hiroe Ohyama, Ken Osaka, Haruhisa Fukuda   +8 more
wiley   +1 more source

Reforming China's retail prescription medicine purchasing system: evidence from retail pharmacies in Wuhan. [PDF]

BMC Health Serv Res
Xu Z, Nicholas S, Maitland E, Wang J, Li J, Tan J.   +5 more
europepmc   +1 more source

European Society for Paediatric Gastroenterology, Hepatology and Nutrition/North American Society for Pediatric Gastroenterology, Hepatology and Nutrition guidelines for treatment of functional constipation in children aged 0–18 years

Journal of Pediatric Gastroenterology and Nutrition, EarlyView.
Abstract Objectives Functional constipation (FC) is common in childhood, significantly impacting quality of life. Since the 2014 international guideline, new evidence has been published, and methods on making guidelines have developed. This treatment guideline for FC in children aged 0–18 years is a collaborative effort of the European and North ...
Morris Gordon, Anna de Geus, Mary Boruta, Marcin Banasiuk, Marc Benninga, Osvaldo Borrelli, Anil Darbari, Dawn Dore‐Stites, Michelle Gould, Juliette Hawa, Kirsten Jones, Alexandra Kilgore, Hayat Mousa, Samuel Nurko, Nikhil Thapar, Julie Khlevner, Vasiliki Sinopoulou, Merit Tabbers   +17 more
wiley   +1 more source

The effect of deductibles on healthcare expenditure: new evidence for Switzerland. [PDF]

BMC Health Serv Res
Felder S, Meyer S.
europepmc   +1 more source

Successful treatment of vertically acquired Hepatitis C in a child using direct‐acting antiviral therapy administered via gastrojejunal tube: A case report

JPGN Reports, EarlyView.
Abstract Hepatitis C virus (HCV) remains a significant global health burden, with vertical transmission being the primary route of infection in children. Direct‐acting antivirals (DAAs) have transformed HCV treatment in pediatrics, but limited data exist on their administration in medically complex children who are dependent on enteral tubes. We report
Connie Chen, Leah Gibson, James Squires
wiley   +1 more source

Access and Reimbursement for Artificial Intelligence in Radiology in Mongolia. [PDF]

Korean J Radiol
Dashjamts T, Bold B, Dagvasumberel M, Tsendjav TE, Khashbat D, Purevsukh T, Dagvasumberel G.   +6 more
europepmc   +1 more source

The U.S. Health Care System: Current Trends and Proposed Reforms [PDF]

Looney, William
core  

Gatekeepers of the Future: The Role of Corporate Venture Capital in Corporate Artificial Intelligence Adoptions

Strategic Change, EarlyView.
ABSTRACT This study extends absorptive capacity research by showing how corporate venture capital (CVC) investments enable corporate artificial intelligence (AI) adoption through collaboration pathways, delineated in four adoption archetypes that explain how heterogeneous AI knowledge is absorbed.
Louisa A. Müller, Marc Neubert, Dominik K. Kanbach   +2 more
wiley   +1 more source

What should infectious diseases clinicians know about pharmacy benefit managers and their impact on our patients? [PDF]

Antimicrob Steward Healthc Epidemiol
Raja K, Acbo A, Jimenez HR, Silverman D, Golia A, Ford AJ, Nori P.   +6 more
europepmc   +1 more source

Efficacy of Lebrikizumab in Patients With Severe Atopic Dermatitis Who Would be Eligible for Treatment Based on the South Korean Reimbursement Criteria

JEADV Clinical Practice, EarlyView.
ABSTRACT Background Lebrikizumab is approved to treat patients with moderate‐to‐severe atopic dermatitis (AD). Objectives This study evaluated the 16‐week efficacy outcomes of lebrikizumab in adults and adolescents with severe AD in ADvocate trials who would be eligible for treatment based on South Korean reimbursement‐like criteria. Methods This was a
Chong Hyun Won, Chun Wook Park, Jiyoung Ahn, Joo Yeon Ko, Sang Hyun Cho, Yang Won Lee, Joo Hee Lee, Khai Jing Ng, Min Young Hong, Jinglin Zhong, Martin Dossenbach, Sang Wook Son   +11 more
wiley   +1 more source